Clinical Trial Update: Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of hydroxychloroquine in previously treated metastatic pancreatic cancer has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14